These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25674594)

  • 21. Etiology of Multiple Non-EV71 and Non-CVA16 Enteroviruses Associated with Hand, Foot and Mouth Disease in Jinan, China, 2009-June 2013.
    Guan H; Wang J; Wang C; Yang M; Liu L; Yang G; Ma X
    PLoS One; 2015; 10(11):e0142733. PubMed ID: 26562154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I Interferons Triggered through the Toll-Like Receptor 3-TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice.
    Yang J; Yang C; Guo N; Zhu K; Luo K; Zhang N; Zhao H; Cui Y; Chen L; Wang H; Gu J; Ge B; Qin CF; Leng Q
    J Virol; 2015 Nov; 89(21):10860-7. PubMed ID: 26292317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5' untranslated region and VP1 region.
    Zhou F; Kong F; Wang B; McPhie K; Gilbert GL; Dwyer DE
    J Med Microbiol; 2011 Mar; 60(Pt 3):349-358. PubMed ID: 21148280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
    Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
    J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
    He SJ; Han JF; Ding XX; Wang YD; Qin CF
    Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanism of antibody neutralization of coxsackievirus A16.
    Zhang C; Liu C; Shi J; Wang Y; Xu C; Ye X; Liu Q; Li X; Qiao W; Yin Y; Cong Y; Huang Z
    Nat Commun; 2022 Dec; 13(1):7854. PubMed ID: 36543790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
    Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
    Liu Q; Ku Z; Cai Y; Sun B; Leng Q; Huang Z
    J Virol Methods; 2011 Apr; 173(1):115-20. PubMed ID: 21295614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synonymous codon usage analysis of hand, foot and mouth disease viruses: A comparative study on coxsackievirus A6, A10, A16, and enterovirus 71 from 2008 to 2015.
    Su W; Li X; Chen M; Dai W; Sun S; Wang S; Sheng X; Sun S; Gao C; Hou A; Zhou Y; Sun B; Gao F; Xiao J; Zhang Z; Jiang C
    Infect Genet Evol; 2017 Sep; 53():212-217. PubMed ID: 28602802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of HiBiT into enteroviruses: A universal tool for advancing enterovirus virology research.
    Yu R; Li X; Zhang P; Xu M; Zhao J; Yan J; Chenli Qiu ; Shu J; Zhang S; Miaomiao Kang ; Zhang X; Xu J; Zhang S
    Virol Sin; 2024 Jun; 39(3):422-433. PubMed ID: 38499155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks.
    Ma E; Fung C; Yip SH; Wong C; Chuang SK; Tsang T
    Pediatr Infect Dis J; 2011 Aug; 30(8):675-9. PubMed ID: 21326133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection.
    Zhang W; Zhang L; Wu Z; Tien P
    Biochem Biophys Res Commun; 2014 May; 447(3):550-5. PubMed ID: 24735544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An outbreak of enterovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis.
    Wang JR; Tsai HP; Chen PF; Lai YJ; Yan JJ; Kiang D; Lin KH; Liu CC; Su IJ
    J Clin Virol; 2000 Aug; 17(2):91-9. PubMed ID: 10942089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
    Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16.
    Chen TC; Chen GW; Hsiung CA; Yang JY; Shih SR; Lai YK; Juang JL
    J Clin Microbiol; 2006 Jun; 44(6):2212-9. PubMed ID: 16757623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease.
    Wang B; Li J; Wang Y; Du N; Sun L; Xiao H; Zhao Y; Bao W; Zhang W
    J Med Virol; 2019 Feb; 91(2):201-207. PubMed ID: 30118553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.